330 likes | 483 Views
Pharmacy Intro. Opioids and other drugs we use on palliative care. Objectives. Discuss the role of opioids in end of life care Discuss the pharmacology and side effects of opioids Discuss opioid equivalencies and conversions Review basics of methadone Discuss other medications commonly used.
E N D
Pharmacy Intro • Opioids and other drugs we use on palliative care
Objectives • Discuss the role of opioids in end of life care • Discuss the pharmacology and side effects of opioids • Discuss opioid equivalencies and conversions • Review basics of methadone • Discuss other medications commonly used
Objectives (cont’d) • Discuss other medications commonly used
Barriers to opioid use • Physician • Patient
Why use opioids • Pain is experienced by over 80% of patients • Over 60% will be moderate to severe • Dyspnea present in 80% of advanced cancer • 95% COPD at end of life • 75% of advanced disease (all comers)
Opioid Pharmacokinetics • All have similar PK (except methadone) • onset of action 15-30 mins • duration of action 4-5 hrs • LA 8-12hrs
Opioid Pharmacokinetics • Fentanyl and Sufentanil • Onset 10-15 mins • Duration 45 mins • First pass metabolism • Highly lipophilic (SL/IN)
Opioid Dosing • No ceiling effect • ↑dose = ↑analgesic effect (log-linear) • Dose increased until symptom relief or limiting side effects
Start with IR dosing • “Start Low and Go Slow” • Q4H • PO = SL = PR • SC/IV = 50% of PO • Reassess regularly
Breakthrough Dose • IR • 50-100% of the Q4H dose or 10% of the 24hr dose • Q1H - PO/SL • Q30Min - SC • Q10Min - IV • For simplicity... all routes are Q1H prn
Titration • Increase equal to total 24 hours breakthrough dose • Mild to moderate pain - 50% • If no response • Increase more rapidly • Switch to parenteral
Opioid Rotation • Why? • Inadequate analgesia despite appropriate escalation • Intractable/Intolerable side effects • Altered renal/hepatic function • Drug shortages
Use a consistent method • Use the same conversion table • Consider incomplete cross-tolerance, patient variations, limitation of tables
Equianalgesia Dose Ratio • Equianalgesia refers to different doses of two agents that provide approximate pain relief • Does not reflect interpatient variability • Ratio differs in acute and chronic use • Does not use incomplete cross tolerance
Fentanyl Patch • For relatively stable pain • Permeates the skin and a depot is formed • 12hrs to develop analgesia • Plasma levels stabilize after 2 sequential patch applications • Half-life about 17 hours after removal
Methadone • Opioid agonist (mu, kappa, delta) • N-methyl-d-aspartate (NMDA) antagonist • Inhibits reuptake of serotonin and noradrenalin • Nociceptive and neuropathic pain
Analgesic effect 30-60mins • Duration 4-6hrs • T1/2 8-100+ hrs (~30hrs) • Peak 1.5-3hrs • Large Vd, 80% bioavailability, large protein binding • Accumulates in chronic use • Metabolized in liver, eliminated in urine and feces • Multiple drug interactions
Side Effects of Opioids • Nausea (50-70%) and Vomiting (15-20%) • Constipation • Sedation • Confusion • Respiratory depression • Urinary retention • Pruritus • ↑ Qt with methadone